However, pre- and co-treatment of morin and/or hesperidin partially prevented these hepatotoxic and nephrotoxic changes in cisplatin-induced groups.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:In this study, we investigated that the histopathological changes of rat kidney and liver tissues after cisplatin administration and potential beneficial effects of morin and hesperidin administration.
Conclusion & Impact:However, pre- and co-treatment of morin and/or hesperidin partially prevented these hepatotoxic and nephrotoxic changes in cisplatin-induced groups.
In this study, we investigated that the histopathological changes of rat kidney and liver tissues after cisplatin administration and potential beneficial effects of morin and hesperidin administration. Wistar rats were randomly divided in 7 groups: control, morin (M), hesperidin (H), cisplatin (CP), cisplatin+morin (CP+M), cisplatin+hesperidin (CP+H), cisplatin+morin+hesperidin (CP+M+H). Kidney and liver tissues were collected at the end of the experiment and were evaluated histopathological changes. Various histopathological changes in kidney and liver tissues of cisplatin-induced group were revealed. However, pre- and co-treatment of morin and/or hesperidin partially prevented these hepatotoxic and nephrotoxic changes in cisplatin-induced groups.
APAYDIN, F. G., KALTALIOĞLU, K., BALABANLI, B., CEVHER, Ş. C. (2018). Morin and Hesperidin Ameliorate Cisplatin-Induced Hepatotoxicity and Nephrotoxicity in Rats: A Histopathological Study. Gazi University Journal of Science, Cilt: 31 - Sayı: 2, 399–406. https://ajindex.com/articles/254459
Radwan, R.R., and Abdel Fattah, S.M., “Mechanisms involved in the possible nephroprotective effect of rutin and low dose γ irradiation against cisplatin-induced nephropathy in rats”, J. Photochem. Photobiol. B Biol., 169: 56–62, (2017)
Shaik, A.N., Altomare, D.A., Lesko, L.J., and Trame, M.N., “Development and validation of a LC–MS/MS assay for quantification of cisplatin in rat plasma and urine”, J. Chromatogr. B 1046: 243–249, (2017)
Nasr, A.Y., “Protective effect of aged garlic extract against the oxidative stress induced by cisplatin on blood cells parameters and hepatic antioxidant enzymes in rats”, Toxicol. Reports. 1: 682–691, (2014)
Yang, Z., Schumake, L.M., Egorin, M.J., E.G., Zuhowski, Z., and Guo, K.J., “Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosis”, Clin. Cancer Res. 12: 5817–5825, (2006)
Omar, H.A., Mohameda, W.R., Arafa, E.A., Shehata, B.A., El Sherbincy, G.A., Arab, H.H., and Elgendy, A.N., “Hesperidin alleviates cisplatin-induced hepatotoxicity in rats without inhibiting its antitumor activity”, Pharmacol. Reports. 68: 349–356, (2016)
Callejo, A., Durochat, A., Bressieux, S., Saleur, A., Chabbert, C., Juan, I.D., Llorens, J., and Gaboyard-Niay, S., “Dose-dependent cochlear and vestibular toxicity of trans-tympanic cisplatin in the rat”, NeuroToxicology, 60: 1–9, (2017)
Heeba, G.H., Hamza, A.A., and Hassanin, S.O., “Induction of heme oxygenase-1 with hemin alleviates cisplatin-induced reproductive toxicity in male rats and enhances its cytotoxicity in prostate cancer cell line”, Toxicol. Lett. 264: 38–50, (2016)
Reddy, K.P., Madhu, P., and Reddy, P.S., “Protective effects of resveratrol against cisplatin-induced testicular and epididymal toxicity in rats”, Food Chem. Toxicol. 91: 65-72, (2016)
El-Awady, E.E., Moustafa, Y.M., Abo-Elmatty, D.M., and Radwan, A., “Cisplatin-induced cardiotoxicity: Mechanisms and cardioprotective strategies”, Eur. J. Pharmacol. 650: 335–341, (2011)
Hassan, M.S., Morgan, A.M., Mekawy, M.M., Zaki, A.R., and Ghazi, Z.M., “Teratogenic effect of cisplatin in rats and the protective role of sodium selenite”, Exp. Toxicol. Pathol. 68: 277–287, (2016)
Szentmihályi, K., Maya, Z., Szénási, G., Máthé, C., Sebestény, A., Albert, M., Hegyi, G., and Blázovics, A., “Changes of essential element content and prevention of cisplati